Sylentis's most advanced  developments are focused on ophtalmology. Sylentis is developing treatments for glaucoma and for dry eye syndrome, two pathologies which are very common for today’s society and whose incidence is expected to increase in the coming years due to population aging and today’s way of life. Click the list for further information: